Bicycle Therapeutics Plc ADR (BCYC)

$8.52 +0.01 (0.12%)
Market Cap 590.04M
Revenue (ttm) 35.28M
Net Income (ttm) -169.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -479.11%
Debt to Equity Ratio 0.02
Volume 249,000
Avg Vol 278,192
Day's Range N/A - N/A
Shares Out 69.25M
Stochastic %K 32%
Beta 1.41
Analysts Strong Sell
Price Target $25.64

Company Profile

Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase I/II/III clinical trials for the treatment of high nectin-4 expressing tumors; BT5528 (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing t...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 1223 261 503
Address:
Portway Building, Blocks A & B Granta Park Great Abington, Cambridge, United Kingdom
Strangperson
Strangperson Jul. 25 at 8:03 PM
$BCYC allergic to $9
0 · Reply
rxptgh
rxptgh Jul. 23 at 2:55 PM
$BCYC
0 · Reply
ford11
ford11 Jul. 22 at 11:51 AM
$BCYC Bid 8.21 ask 9.2.. Big spread, hmmm
0 · Reply
ford11
ford11 Jul. 21 at 8:14 PM
$BCYC Its a buy at 8.3
0 · Reply
ford11
ford11 Jul. 19 at 6:32 PM
$BCYC $BCYC I just did some TA on this ticker... Looks nasty...
0 · Reply
rxptgh
rxptgh Jul. 19 at 1:50 AM
$BCYC going higher
0 · Reply
JarvisFlow
JarvisFlow Jul. 17 at 2:08 PM
RBC Capital updates rating for Bicycle Therapeutics ( $BCYC ) to Outperform, target set at 32 → 25.
0 · Reply
BiotechBonesaw
BiotechBonesaw Jul. 15 at 3:47 PM
$BCYC what’s going on? Entry point or should we wait a big longer? 🧐
1 · Reply
kclan
kclan Jul. 9 at 8:06 PM
$BCYC Good form by the BOD to all purchase shares last week. At least it shows some confidence in the company during the stock price decline. Hopefully more good news soon.
1 · Reply
rxptgh
rxptgh Jul. 8 at 3:30 PM
$BCYC biotechs are heating up
0 · Reply
Latest News on BCYC
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 2, 2025, 4:05 PM EDT - 4 weeks ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting

May 22, 2025, 5:05 PM EDT - 2 months ago

Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

May 1, 2025, 7:00 AM EDT - 3 months ago

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025

Apr 29, 2025, 7:00 AM EDT - 3 months ago

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025

Bicycle Therapeutics: Maybe Underwhelming, But I Don't Think They Should Be This Discounted

Apr 22, 2025, 3:47 AM EDT - 3 months ago

Bicycle Therapeutics: Maybe Underwhelming, But I Don't Think They Should Be This Discounted

Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments

Mar 27, 2025, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 7:00 AM EST - 5 months ago

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 7:00 AM EST - 6 months ago

Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Bicycle Therapeutics: Trading At Cash, Underwhelming But Not Unsalvageable Data

Feb 2, 2025, 5:26 AM EST - 6 months ago

Bicycle Therapeutics: Trading At Cash, Underwhelming But Not Unsalvageable Data

Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones

Jan 13, 2025, 7:00 AM EST - 7 months ago

Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones

Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 7:00 AM EST - 7 months ago

Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification

Dec 12, 2024, 6:30 PM EST - 8 months ago

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification

Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts

Dec 10, 2024, 7:00 AM EST - 8 months ago

Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts

Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update

Nov 25, 2024, 5:30 PM EST - 8 months ago

Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

Nov 12, 2024, 7:00 AM EST - 9 months ago

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

Bicycle Therapeutics: Looking Again At An Intriguing Developmental Concern

Nov 7, 2024, 10:04 AM EST - 9 months ago

Bicycle Therapeutics: Looking Again At An Intriguing Developmental Concern

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Oct 31, 2024, 7:00 AM EDT - 9 months ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals

Oct 23, 2024, 7:00 AM EDT - 10 months ago

Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals

Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress

Oct 16, 2024, 7:00 AM EDT - 10 months ago

Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Sep 14, 2024, 3:00 AM EDT - 11 months ago

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone

Sep 6, 2024, 1:37 PM EDT - 11 months ago

Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Aug 21, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Bicycle Therapeutics Is Looking Increasingly Attractive

Aug 20, 2024, 7:37 AM EDT - 1 year ago

Bicycle Therapeutics Is Looking Increasingly Attractive

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

Aug 6, 2024, 7:05 AM EDT - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

Aug 6, 2024, 7:00 AM EDT - 1 year ago

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

BSY MASS MLI NJR OFIX QBTS SMMT

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Jul 22, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting

May 23, 2024, 5:05 PM EDT - 1 year ago

Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting

Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

May 23, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Apr 24, 2024, 10:05 AM EDT - 1 year ago

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Apr 2, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

2 More Potential Biotech Buyout Targets

Mar 25, 2024, 1:07 PM EDT - 1 year ago

2 More Potential Biotech Buyout Targets

AZN BMY EXEL LLY MRK NVS TAK

Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point

Mar 12, 2024, 12:09 PM EDT - 1 year ago

Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point

Bicycle Therapeutics to Present at the AACR Annual Meeting 2024

Mar 5, 2024, 4:35 PM EST - 1 year ago

Bicycle Therapeutics to Present at the AACR Annual Meeting 2024

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Feb 20, 2024, 7:05 AM EST - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Feb 7, 2024, 7:00 AM EST - 1 year ago

Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

Dec 14, 2023, 7:00 AM EST - 1 year ago

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

Bicycle Therapeutics to Host R&D Day on December 14

Nov 30, 2023, 7:00 AM EST - 1 year ago

Bicycle Therapeutics to Host R&D Day on December 14

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day

Nov 2, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day

Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer

Oct 19, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer

Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director

Oct 19, 2023, 4:00 AM EDT - 1 year ago

Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director

Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer

Sep 11, 2023, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer

Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Sep 5, 2023, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 3, 2023, 6:59 AM EDT - 2 years ago

Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Bicycle Therapeutics: Decent Upside Opportunity, Mid-Stage Data Readouts Due

Jul 31, 2023, 7:07 PM EDT - 2 years ago

Bicycle Therapeutics: Decent Upside Opportunity, Mid-Stage Data Readouts Due

Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jul 18, 2023, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares

Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares

Jul 12, 2023, 10:23 PM EDT - 2 years ago

Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares

Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares

Jul 12, 2023, 4:01 PM EDT - 2 years ago

Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares

Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer

Jun 23, 2023, 7:30 AM EDT - 2 years ago

Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer

Strangperson
Strangperson Jul. 25 at 8:03 PM
$BCYC allergic to $9
0 · Reply
rxptgh
rxptgh Jul. 23 at 2:55 PM
$BCYC
0 · Reply
ford11
ford11 Jul. 22 at 11:51 AM
$BCYC Bid 8.21 ask 9.2.. Big spread, hmmm
0 · Reply
ford11
ford11 Jul. 21 at 8:14 PM
$BCYC Its a buy at 8.3
0 · Reply
ford11
ford11 Jul. 19 at 6:32 PM
$BCYC $BCYC I just did some TA on this ticker... Looks nasty...
0 · Reply
rxptgh
rxptgh Jul. 19 at 1:50 AM
$BCYC going higher
0 · Reply
JarvisFlow
JarvisFlow Jul. 17 at 2:08 PM
RBC Capital updates rating for Bicycle Therapeutics ( $BCYC ) to Outperform, target set at 32 → 25.
0 · Reply
BiotechBonesaw
BiotechBonesaw Jul. 15 at 3:47 PM
$BCYC what’s going on? Entry point or should we wait a big longer? 🧐
1 · Reply
kclan
kclan Jul. 9 at 8:06 PM
$BCYC Good form by the BOD to all purchase shares last week. At least it shows some confidence in the company during the stock price decline. Hopefully more good news soon.
1 · Reply
rxptgh
rxptgh Jul. 8 at 3:30 PM
$BCYC biotechs are heating up
0 · Reply
rxptgh
rxptgh Jul. 7 at 5:27 PM
$BCYC love the potential here
0 · Reply
rxptgh
rxptgh Jul. 7 at 5:16 PM
$BCYC added
0 · Reply
rxptgh
rxptgh Jul. 7 at 1:10 AM
$REPL $BCYC both adds for me tomorrow
1 · Reply
kclan
kclan Jul. 2 at 4:21 PM
$BCYC
0 · Reply
btown_moneymike
btown_moneymike Jul. 1 at 10:10 PM
$BCYC
1 · Reply
kclan
kclan Jun. 24 at 4:51 PM
$BCYC get the bike off the shoulder and start making some miles!
0 · Reply
SmartestMoney
SmartestMoney Jun. 18 at 6:56 PM
$BCYC
0 · Reply
50bps
50bps Jun. 18 at 6:56 PM
$BCYC
0 · Reply
Strangperson
Strangperson Jun. 18 at 4:12 PM
$BCYC
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 16 at 6:58 PM
$SPRB i'm posting this here and here only $BCYC negative EV a whole bunch of programs (check their website) baker brothers bought in at much higher prices felix baker taking over as chairman today do your own research I added today
5 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Jun. 11 at 7:23 PM
$BCYC still a chance to buy under 9 anyone interested ?
1 · Reply
SmartestMoney
SmartestMoney Jun. 11 at 3:20 PM
$BCYC Do it
1 · Reply